2,2,5,5-tetrachloro-hexane | 99585-03-2

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 有机氯化物
• 英文名称: 2,2,5,5-tetrachloro-hexane
• 英文别名: 2,2,5,5-Tetrachlor-hexan；2,2,5,5-Tetrachlorohexane；2,2,5,5-tetrachlorohexane
• CAS: 99585-03-2
• 化学式: C₆H₁₀Cl₄
• 分子量: 223.957
• InChiKey: GEVAXGJHVAOPCY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  10
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为产物：
  描述：

  三聚丙烯 在 五氯化磷 作用下， 生成 2,2,5,5-tetrachloro-hexane
  参考文献：
  名称：

  Hypersonic Flow over a Blunt Body with Plasma Injection

  摘要：

  The drag reduction of blunt body in hypersonic flow via plasma injection has been investigated by a combined experimental and computational effort. The counterflow plasma jet generated by a plasma torch has a vibrionic temperature of 4400 K, an electronic temperature around 20,000 K, and electron density greater than 3 x 10(12)/cm(3). At a fixed injection stagnation pressure and in the absence of an applied magnetic field, the plasma injection actually increases drag above that of room-temperature air due to a decreased mass flow rate at the elevated temperature. However, at an identical mass flow rate, the plasma injection reveals a greater drag reduction than the room-temperature air counterpart through thermal energy deposition. From experimental measurements, an overwhelming major portion of the drag reduction is derived from the viscous-inviscid interaction of the counterflow jet and thermal energy deposition. The numerical results of Navier-Stokes equations with a local equilibrium plasma composition also confirm this observation.

  DOI：

  10.2514/2.3835

文献信息

• [EN] STABLY-TRANSFORMED MAMMALIAN CELLS EXPRESSING A REGULATED, INFLAMMATORY CYCLOOXYGENASE<br/>[FR] CELLULES DE MAMMIFERES A TRANSFORMATION STABLE EXPRIMANT UNE CYCLOOXYGENASE INFLAMMATOIRE REGULEE
  申请人：——

  公开号：WO1994006919A2

  公开（公告）日：1994-03-31

  [EN] A transgenic mammalian cell line is provided which contains chromosomally integrated, recombinant DNA, wherein said DNA expresses mammalian glucocorticoid-regulated inflammatory prostaglandin G/H synthase (griPGHS), and wherein said DNA does not express constitutive PGHS, and wherein the cell line does not express endogenous PGHS activity.
  [FR] L'invention concerne une ligne de cellules transgéniques de mammifères contenant un ADN recombinant et chromosomiquement intégré, où ledit ADN exprime la G/H synthase de la prostaglandine inflammatoire régulée par glucocorticoïde (griPGHS) chez les mammifères, ou ledit ADN n'exprime pas la PGHS constitutive et où la ligne cellulaire n'exprime pas l'activité endogène de PGHS.